Global clinical dementia rating of 0.5 in MCI masks variability related to level of function

Y-L Chang1, M W Bondi, L K McEvoy

  • 1Department of Psychology, National Taiwan University, Taipei, 10617 Taiwan. ychang@ntu.edu.tw

Neurology
|February 16, 2011
PubMed
Abstract

Insights

Instrumental activities of daily living (IADL) impairment in mild cognitive impairment (MCI) is linked to significant brain changes and faster progression to Alzheimer disease (AD). This highlights the need to better utilize IADL data in MCI assessments.

Area of Science:

  • Neurology
  • Gerontology
  • Neuroscience

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • The Clinical Dementia Rating (CDR) scale assesses cognitive and functional status.
  • Instrumental activities of daily living (IADL) are crucial for independent living.

Purpose of the Study:

  • To determine if CDR IADL item ratings correlate with cognitive and brain characteristics in MCI patients with a global CDR score of 0.5.
  • To investigate the association between IADL performance and brain morphometry in MCI.
  • To compare the rate of progression to Alzheimer disease (AD) based on IADL status.

Main Methods:

  • Analysis of baseline cognitive and morphometric data from 283 individuals with MCI.
  • Participants were categorized into 'impaired' and 'intact' IADL groups based on CDR IADL item scores.
  • Comparison of Alzheimer disease (AD) progression rates over two years between the two IADL groups.

Main Results:

  • The MCI group with impaired IADL showed greater gray matter loss in frontal and parietal regions.
  • Worse episodic memory and executive functions were observed in the impaired IADL group.
  • A higher percentage of individuals in the impaired IADL group progressed to AD.

Conclusions:

  • Functional information from CDR IADL items is vital for evaluating MCI, even if not heavily weighted in global scores.
  • IADL impairment in MCI is associated with broader brain region involvement beyond the mesial temporal lobe.
  • Relying solely on the global CDR score may delay the identification of high-risk MCI individuals.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...